publication date: Nov. 16, 2010
In this issue:
Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study Lasofoxifene Reduced Breast Cancer Risk
In Postmenopausal Osteoporotic Women
Higher With Silicone Implants
More Breast Cancer Patients Opting For Double Mastectomy BRAF Inhibitor Shrank Melanoma Tumors In Phase II Trial Prostate Ca. Patients On ADT Had Higher Risk of Colon Cancer NCI-Approved Trials Listed
To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us
and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here
You will be given immediate access to premium content on the site.
Click here to join.